Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Guofeng He, Xiaoke Di, Xinchen Sun, Jingjing Yan & Shu Zhang. (2017) Analysis of radio-sensitization patents in China from 2006 to 2015. Expert Opinion on Therapeutic Patents 27:10, pages 1159-1172.
Read now
Read now
Brian M Alexander, Keith L Ligon & Patrick Y Wen. (2013) Enhancing radiation therapy for patients with glioblastoma. Expert Review of Anticancer Therapy 13:5, pages 569-581.
Read now
Read now
Francis Dumont, Antoine Le Roux & Pierre Bischoff. (2010) Radiation countermeasure agents: an update. Expert Opinion on Therapeutic Patents 20:1, pages 73-101.
Read now
Read now
Francis Dumont, Anais Altmeyer & Pierre Bischoff. (2009) Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches. Expert Opinion on Therapeutic Patents 19:6, pages 775-799.
Read now
Read now
Articles from other publishers (29)
Diana Diaz-Dussan, Yi-Yang Peng, Faisal Bin Rashed, Dawn Macdonald, Michael Weinfeld, Piyush Kumar & Ravin Narain. (2023) Optimized Carbohydrate-Based Nanogel Formulation to Sensitize Hypoxic Tumors. Molecular Pharmaceutics 20:6, pages 3100-3114.
Crossref
Crossref
Hannah I. Hoffman, Jimmy A. Guo & William L. Hwang. 2023. Translational Radiation Oncology. Translational Radiation Oncology
39
43
.
Lili Qian, Qian Li, Zhenshan Ding, Kejun Luo, Jiamin Su, Jiawei Chen, Guangying Zhu, Zhihua Gan & Qingsong Yu. (2022) Prodrug Nanosensitizer Overcomes the Radiation Resistance of Hypoxic Tumor. ACS Applied Materials & Interfaces 14:51, pages 56454-56470.
Crossref
Crossref
Jung Mo Lee, Hey Soo Kim, Arum Kim, Yoon Soo Chang, Jin Gu Lee, Jaeho Cho & Eun Young Kim. (2022) ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model. Yonsei Medical Journal 63:1, pages 16.
Crossref
Crossref
Xinyu Zhang, Yanling Ma, Jipeng Wan, Jia Yuan, Diqing Wang, Weiyi Wang, Xiao Sun & Qingwei Meng. (2021) Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics. Frontiers in Chemistry 9.
Crossref
Crossref
Luiza Steffens, Mabilly Cox Holanda de Barros Dias, Pablo Ricardo Arantes, Jeferson Gustavo Henn, Michael Nugent & Dinara Jaqueline Moura. 2021. Advances and Challenges in Pharmaceutical Technology. Advances and Challenges in Pharmaceutical Technology
355
394
.
Adam Frtús, Barbora Smolková, Mariia Uzhytchak, Mariia Lunova, Milan Jirsa, Šárka Kubinová, Alexandr Dejneka & Oleg Lunov. (2020) Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications. Journal of Controlled Release 328, pages 59-77.
Crossref
Crossref
Stefanie Klein, Matthias Smuda, Christina Harreiß, Christina Menter, Luitpold V. R. Distel & Carola Kryschi. (2019)
Bifunctional Au–Fe
3
O
4
Nanoheterodimers Acting as X-ray Protector in Healthy Cells and as X-ray Enhancer in Tumor Cells
. ACS Applied Materials & Interfaces 11:43, pages 39613-39623.
Crossref
Crossref
Robin Schürmann, Stefanie Vogel, Kenny Ebel & Ilko Bald. (2018) The Physico-Chemical Basis of DNA Radiosensitization: Implications for Cancer Radiation Therapy. Chemistry - A European Journal 24:41, pages 10271-10279.
Crossref
Crossref
Stefanie Klein, Marc Wegmann, Luitpold V.R. Distel, Winfried Neuhuber & Carola Kryschi. (2018) APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy. Biochemical and Biophysical Research Communications 498:4, pages 855-861.
Crossref
Crossref
Lingtong Meng, Yali Cheng, Shaoju Gan, Zhicheng Zhang, Xiaoning Tong, Lei Xu, Xing Jiang, Yishen Zhu, Jinhui Wu, Ahu Yuan & Yiqiao Hu. (2018) Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy. Molecular Pharmaceutics 15:2, pages 447-457.
Crossref
Crossref
Anita Tandle, Uma Shankavaram, Cody Schlaff, Kevin Camphausen & Andra Krauze. 2016. Radiobiology of Glioblastoma. Radiobiology of Glioblastoma
255
274
.
Bola Sadashiva Satish Rao, Mandala Rayabandla Sunil Kumar, Shubhankar Das, Kiran Aithal & Nayanabhirama Udupa. (2015) Radiosensitizing potential of Plumbagin in B16F1 melanoma tumor cells through mitochondrial mediated programmed cell death. Journal of Applied Biomedicine 13:4, pages 279-288.
Crossref
Crossref
CHANGBIN YANG, WEI HUANG, LING YAN, YU WANG, WEILI WANG, DEZHI LIU & XIAOJUN ZUO. (2015) Downregulation of the expression of B-cell lymphoma-extra large by RNA interference induces apoptosis and enhances the radiosensitivity of non-small cell lung cancer cells. Molecular Medicine Reports 12:1, pages 449-455.
Crossref
Crossref
Lucheng Zhu, Kan Wu, Shenglin Ma & Shirong Zhang. (2015) HDAC Inhibitors: A New Radiosensitizer for Non-small-cell Lung Cancer. Tumori Journal 101:3, pages 257-262.
Crossref
Crossref
Shubhangi Agarwal, Rohini Vidya Shankar, Landon J. Inge & Vikram Kodibagkar. MRI assessment of changes in tumor oxygenation post hypoxia-targeted therapy. MRI assessment of changes in tumor oxygenation post hypoxia-targeted therapy.
HENG-CHENG ZHU, TAO QIU, CHAO DAN, XIU-HENG LIU & CHUN-HAI HU. (2015) Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen-independent prostate cancer cells. Molecular Medicine Reports 11:2, pages 1167-1173.
Crossref
Crossref
Laura E Taggart, Stephen J McMahon, Fred J Currell, Kevin M Prise & Karl T Butterworth. (2014) The role of mitochondrial function in gold nanoparticle mediated radiosensitisation. Cancer Nanotechnology 5:1.
Crossref
Crossref
Shijie Zhang, Lei Wang, Hongchun Liu, Guoqiang Zhao & Liang Ming. (2014) Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells. Diagnostic Pathology 9:1.
Crossref
Crossref
Stefanie Klein, Anja Sommer, Luitpold V. R. Distel, Jean-Louis Hazemann, Wolfgang Kröner, Winfried Neuhuber, Paul Müller, Olivier Proux & Carola Kryschi. (2014) Superparamagnetic Iron Oxide Nanoparticles as Novel X-ray Enhancer for Low-Dose Radiation Therapy. The Journal of Physical Chemistry B 118:23, pages 6159-6166.
Crossref
Crossref
RONGXIN QI, WENWEN JIN, JUAN WANG, QIYI YI, MAOHU YU, SHIGUO XU & WENSEN JIN. (2014) Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression. Oncology Reports 31:5, pages 2399-2406.
Crossref
Crossref
M. Langenbacher, R.J. Abdel-Jalil, W. Voelter, M. Weinmann & S.M. Huber. (2013) In vitro hypoxic cytotoxicity and hypoxic radiosensitizationHypoxische Zytotoxizität und Strahlensensibilisierung in vitro. Strahlentherapie und Onkologie 189:3, pages 246-255.
Crossref
Crossref
Shu-Dong Yu, Fen-Ye Liu & Qi-Rong Wang. (2012) Notch Inhibitor: a Promising Carcinoma Radiosensitizer. Asian Pacific Journal of Cancer Prevention 13:11, pages 5345-5351.
Crossref
Crossref
WEIDONG WANG & JINYI LANG. (2012) Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue. Experimental and Therapeutic Medicine 4:2, pages 175-180.
Crossref
Crossref
Kiran B. Aithal, Sunil Kumar, B. Nageshwar Rao, Nayanabhirama Udupa & Satish Bola Sadashiva Rao. (2011) Tumor Growth Inhibitory Effect of Juglone and Its Radiation Sensitizing Potential. Integrative Cancer Therapies 11:1, pages 68-80.
Crossref
Crossref
Thomas Efferth & Peter Langguth. (2011) Transport processes of radiopharmaceuticals and -modulators. Radiation Oncology 6:1.
Crossref
Crossref
Bryan T. Oronsky, Susan J. Knox & Jan Scicinski. (2011) Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers. Translational Oncology 4:4, pages 189-198.
Crossref
Crossref
Jagat R. Kanwar, Sishir K. Kamalapuram & Rupinder K. Kanwar. (2011) Targeting survivin in cancer: the cell-signalling perspective. Drug Discovery Today 16:11-12, pages 485-494.
Crossref
Crossref
Byung J. Kim, Trevor W. Hambley & Nicole S. Bryce. (2011) Visualising the hypoxia selectivity of cobalt(iii) prodrugs. Chemical Science 2:11, pages 2135.
Crossref
Crossref